| abstract |
The present invention relates to a compound of formula (I), or a pharmaceutically acceptable enantiomer, salt or solvate thereof. The invention further relates to the use of compounds of formula I as tryptophan 2,3-dioxygenase (TDO2) inhibitors. The present invention relates to the use of compounds of formula I for the treatment and / or prevention of cancer, Parkinson's disease, neurodegenerative disorders such as Alzheimer's disease and Huntington's disease, chronic viral infections such as HCV and HIV, depression and obesity Also related. The invention also relates to a process for preparing the compound of formula (I). [Chemical 1] |